39752998|t|Molecular hydrogen reduces dermatitis-induced itch, diabetic itch and cholestatic itch by inhibiting spinal oxidative stress and synaptic plasticity via SIRT1-beta-catenin pathway in mice.
39752998|a|Chronic itch which is primarily associated with dermatologic, systemic, or metabolic disorders is often refractory to most current antipruritic medications, thus highlighting the need for improved therapies. Oxidative damage is a novel determinant of spinal pruriceptive sensitization and synaptic plasticity. The resolution of oxidative insult by molecular hydrogen has been manifested. Herein, we strikingly report that both hydrogen gas (2 %) inhalation and hydrogen-rich saline (5 mL/kg, intraperitoneal) injection prevent and alleviate persistent dermatitis-induced itch, diabetic itch and cholestatic itch. Hydrogen therapy reverses the decrease of spinal SIRT1 expression and antioxidant enzymes (SOD, GPx and CAT) activity after dermatitis, diabetes and cholestasis. Furthermore, hydrogen reduces spinal ROS generation, oxidation products (MDA, 8-OHdG and 3-NT) accumulation, beta-catenin acetylation and dendritic spine density in persistent itch models. Spinal SIRT1 inhibition eliminates antipruritic and antioxidative effects of hydrogen, while SIRT1 agonism attenuates chronic itch phenotype, spinal beta-catenin acetylation and mitochondrial damage. beta-catenin inhibitors are effective against chronic itch via reducing beta-catenin acetylation, blocking ERK phosphorylation and elevating antioxidant enzymes activity. Hydrogen treatment suppressed dermatitis and cholestasis mediated spontaneous excitatory postsynaptic currents in vitro. Additionally, hydrogen impairs cholestasis-induced the enhancement of cerebral functional connectivity between the right primary cingulate cortex and bilateral sensorimotor cortex, as well as bilateral striatum. Taken together, this study uncovers that molecular hydrogen protects against chronic pruritus and spinal pruriceptive sensitization by reducing oxidative damage via up-regulation of SIRT1-dependent beta-catenin deacetylation in mice, implying a promising strategy in translational development for itch control.
39752998	10	18	hydrogen	Chemical	MESH:D006859
39752998	27	37	dermatitis	Disease	MESH:D003872
39752998	46	50	itch	Disease	MESH:D011537
39752998	52	65	diabetic itch	Disease	MESH:D011537
39752998	70	86	cholestatic itch	Disease	MESH:D011537
39752998	153	158	SIRT1	Gene	23411
39752998	159	171	beta-catenin	Gene	1499
39752998	183	187	mice	Species	10090
39752998	189	201	Chronic itch	Disease	MESH:D011537
39752998	264	283	metabolic disorders	Disease	MESH:D008659
39752998	547	555	hydrogen	Chemical	MESH:D006859
39752998	616	624	hydrogen	Chemical	MESH:D006859
39752998	650	658	hydrogen	Chemical	MESH:D006859
39752998	741	751	dermatitis	Disease	MESH:D003872
39752998	760	764	itch	Disease	MESH:D011537
39752998	766	779	diabetic itch	Disease	MESH:D011537
39752998	784	800	cholestatic itch	Disease	MESH:D011537
39752998	802	810	Hydrogen	Chemical	MESH:D006859
39752998	851	856	SIRT1	Gene	23411
39752998	893	896	SOD	Gene	6647
39752998	906	909	CAT	Gene	847
39752998	926	936	dermatitis	Disease	MESH:D003872
39752998	938	946	diabetes	Disease	MESH:D003920
39752998	951	962	cholestasis	Disease	MESH:D002779
39752998	977	985	hydrogen	Chemical	MESH:D006859
39752998	1001	1004	ROS	Chemical	-
39752998	1037	1040	MDA	Chemical	MESH:D015104
39752998	1042	1048	8-OHdG	Chemical	MESH:D000080242
39752998	1053	1057	3-NT	Chemical	MESH:C002744
39752998	1073	1085	beta-catenin	Gene	1499
39752998	1140	1144	itch	Disease	MESH:D011537
39752998	1160	1165	SIRT1	Gene	23411
39752998	1230	1238	hydrogen	Chemical	MESH:D006859
39752998	1246	1251	SIRT1	Gene	23411
39752998	1271	1283	chronic itch	Disease	MESH:D011537
39752998	1302	1314	beta-catenin	Gene	1499
39752998	1331	1351	mitochondrial damage	Disease	MESH:D028361
39752998	1353	1365	beta-catenin	Gene	1499
39752998	1399	1411	chronic itch	Disease	MESH:D011537
39752998	1425	1437	beta-catenin	Gene	1499
39752998	1460	1463	ERK	Gene	5594
39752998	1524	1532	Hydrogen	Chemical	MESH:D006859
39752998	1554	1564	dermatitis	Disease	MESH:D003872
39752998	1569	1580	cholestasis	Disease	MESH:D002779
39752998	1659	1667	hydrogen	Chemical	MESH:D006859
39752998	1676	1687	cholestasis	Disease	MESH:D002779
39752998	1908	1916	hydrogen	Chemical	MESH:D006859
39752998	1942	1950	pruritus	Disease	MESH:D011537
39752998	2039	2044	SIRT1	Gene	23411
39752998	2055	2067	beta-catenin	Gene	1499
39752998	2085	2089	mice	Species	10090
39752998	2154	2158	itch	Disease	MESH:D011537
39752998	Association	MESH:D011537	1499
39752998	Positive_Correlation	MESH:D006859	23411
39752998	Negative_Correlation	MESH:D006859	1499
39752998	Negative_Correlation	MESH:D006859	MESH:D002779
39752998	Positive_Correlation	MESH:D028361	23411
39752998	Association	MESH:D011537	23411
39752998	Negative_Correlation	MESH:D006859	MESH:D011537
39752998	Association	MESH:D002779	1499
39752998	Negative_Correlation	MESH:D000080242	MESH:D006859
39752998	Positive_Correlation	1499	5594
39752998	Negative_Correlation	MESH:D006859	MESH:D015104
39752998	Negative_Correlation	MESH:D006859	6647
39752998	Association	1499	23411
39752998	Negative_Correlation	MESH:D006859	MESH:D003872
39752998	Association	MESH:D002779	23411
39752998	Negative_Correlation	MESH:D006859	847
39752998	Negative_Correlation	MESH:D006859	MESH:D003920
39752998	Association	MESH:D003872	1499
39752998	Negative_Correlation	MESH:C002744	MESH:D006859

